Australia markets closed

Cannabis stocks

Cannabis stocks

165.12k followers20 symbols Watchlist by Yahoo Finance

Follow this list to discover and track the stock of publicly traded companies with exposure to cannabis

Curated by Yahoo Finance


Global spending on legal cannabis worldwide will hit over £43 billion in a decade, according to Arcview Market Research and BDS Analytics. Driven by the legalisation of recreational and medical cannabis and the increasing demand for both, legal cannabis revenue in the US is projected to hit £17.8 billion by 2022. Yahoo Finance is now tracking the major players in the cannabis industry.

How do we pick these stocks?

This is a curated list, powered by Yahoo Finance’s algorithm and intelligence from our millions of users as well as the Yahoo Finance editorial team. The list covers companies in horticulture, pharmaceutical research and ancillary businesses. We will continue to add names as corporations invest and pivot into the space.

How are these weighted?

The stocks on this watchlist are weighted equally at the time they were added.

To learn what every company on this list is doing that involves cannabis, read this story.


WatchlistChange today1-month return1-year returnTotal return
Cannabis stocks+5.94%+58.10%-9.72%+327.19%

20 symbols

SymbolCompany nameLast priceChange% changeMarket timeVolumeAvg vol (3-month)Market cap
ABBVAbbVie Inc.167.8-1.74-1.03%4:00 pm GMT-43.97M5.62M297.12B
BUDAnheuser-Busch InBev SA/NV60.26+0.08+0.13%4:00 pm GMT-41.15M2.22M118.77B
MOAltria Group, Inc.42.92+0.05+0.12%4:00 pm GMT-412.43M12.83M73.72B
TAPMolson Coors Beverage Company63.7-0.48-0.75%4:00 pm GMT-42.36M1.77M13.52B
SMGThe Scotts Miracle-Gro Company68.52-0.06-0.09%4:00 pm GMT-4389.30k777.43k3.88B
TLRYTilray Brands, Inc.1.84--4:00 pm GMT-417.67M29.71M1.42B
WEED.TOCanopy Growth Corporation12.27-0.06-0.49%4:00 pm GMT-42.74M3.03M1.12B
CRONCronos Group Inc.2.48+0.01+0.40%4:00 pm GMT-42.49M3.06M951.69M
CGCCanopy Growth Corporation8.97-0.06-0.66%4:00 pm GMT-47.43M11.74M818.29M
ACBAurora Cannabis Inc.7.2-0.22-2.96%4:00 pm GMT-45.74M5.97M392.68M
CRBPCorbus Pharmaceuticals Holdings, Inc.35.54-2.20-5.83%4:00 pm GMT-4219.99k992.60k373.43M
CANNTrees Corporation0.086-0.00-3.26%3:56 pm GMT-438.52k94.91k9.35M
MJAmplify Alternative Harvest ETF3.87-0.01-0.26%4:00 pm GMT-42.02M3.10M-
NBEV-0.0935-0.03-25.20%4:00 pm GMT-446.01M--
  • GlobeNewswire

    Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting

    NORWOOD, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that an abstract providing updated data from the Phase 1, first-in-human clinical data from a dose escalation study being carried out by its partner CSPC in China with CRB-701 (SYS6002) has been accepted for presentation at the 2024 American Society of Clinical Oncology annual meeting, to be held May 31-June 4, 2024 in Chicago, IL. CRB-701 (SYS6002)

  • Zacks

    Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?

    While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.

  • Zacks

    4 Large Drug Stocks to Hold on to Amid Industry Challenges

    Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and AbbVie (ABBV) are worth retaining in one's portfolio.